Chemical restraint involves using medication that is intended to prevent, restrict or subdue a person’s movement. It’s a practice used in various settings, including hospitals, care homes, and mental health facilities. It may only be considered as a last resort, where there is a real risk of harm to a person, and it is a contentious and complex topic.
Definition and Purpose
Chemical restraint means using medication that is intended to prevent, restrict or subdue a person’s movement. In mental health units in England this is defined in the Mental Health Units (Use of Force) Act 2018 and includes rapid tranquillisation. It may be considered only as a last resort, where there is a real risk of harm to the person or to others. If someone is in immediate danger to life, call 999 and follow your organisation’s emergency procedure (see when to call 999 on NHS.UK).
- Temporary Measure: It’s usually a temporary measure, rather than a permanent solution.
- Safety: Primarily, it’s about safety — for the person restrained and those around them.
When is Chemical Restraint Used?
Chemical restraint isn’t the first option. It’s typically considered when other interventions have failed.
Situations Requiring Chemical Restraint
- Acute Psychiatric Episodes: A person in a severe mental health crisis may be at risk of harming themselves or others.
- Dementia and Distress: Distress in a person living with dementia can have causes, such as pain, illness or inappropriate care. Staff should look for and address the cause and use person-centred support first. Medicines should only be considered in line with current clinical guidance; see NICE guidance on dementia.
- Severe Agitation: A person who is extremely agitated and at risk of harming themselves or others, when other ways of helping them to calm have not worked.
Ethical Considerations
The use of chemical restraint is fraught with ethical concerns.
- Autonomy: It can infringe on a person’s autonomy and freedom.
- Consent: Care and treatment must only be provided with valid consent. Where a person lacks capacity, providers must act in line with the Mental Capacity Act 2005 and, where Part 4 or 4A of the Mental Health Act 1983 applies, with that Act.
- Care Quality: Over-reliance on chemical restraint may reflect poor care practices.
Legal and Regulatory Framework
In England, chemical restraint is regulated by several laws and standards, including CQC Regulation 13 and, for mental health units, the Mental Health Units (Use of Force) Act 2018 statutory guidance. The rules differ between UK nations, so check the law that applies where you work.
Relevant Legislation
- Mental Health Act 1983: This Act provides a legal framework for the compulsory treatment of individuals with mental health conditions.
- Deprivation of Liberty Safeguards (DoLS): Part of the Mental Capacity Act 2005 (England and Wales), DoLS apply to adults aged 18 or over in hospitals and care homes who lack capacity to consent to their care and living arrangements, where there may be a deprivation of liberty. The definition changed after a Supreme Court judgment on 2 June 2026, so check the latest DHSC guidance.
- Care Quality Commission (CQC): In England, CQC regulates health and social care providers. Under Regulation 13, control or restraint, including by chemical means, must be necessary and a proportionate response to a risk of harm.
Risks and Side Effects
Chemical restraint carries serious risks, including potential side effects from the medicines used.
- Physical Health: Medicines used in this way can have side effects that affect a person’s health and quality of life. People should only be given psychotropic medication for the right reasons, at the lowest dose and for the shortest time. See the NHS England page on STOMP and STAMP and ask the prescriber or pharmacist about the medicines concerned.
Alternative Strategies
There are numerous alternatives to chemical restraint that should be considered before medication.
Non-Pharmacological Approaches
- De-escalation Techniques: Training staff in de-escalation methods can actually reduce the need for chemical restraint.
- Environmental Adjustments: Altering the environment to minimise triggers for agitation and aggression.
- Therapeutic Interventions: Person-centred psychological and social support, agreed with the person and their care team and in line with current NICE guidance on violence and aggression.
Case Studies and Examples
Example 1: Dementia Care
Mrs. Smith, an 82-year-old with advanced dementia, often becomes aggressive. Staff initially used chemical restraint, following a risk assessment. However, after implementing a more structured daily routine, the reliance on medication decreased.
Example 2: Mental Health Crisis
John, aged 34, had a severe psychotic episode. Standard interventions failed, leading to a short-term use of chemical restraint. Over time, with consistent therapy and support, John no longer required such measures.
Best Practices for Implementation
Implementing chemical restraint should follow best practices to ensure safety and ethical integrity.
- Comprehensive Assessment: Always conduct a thorough assessment to identify the root cause of the behaviour and explore alternatives.
- Informed Consent: Check consent and capacity for the specific decision. Where a person lacks capacity, follow the Mental Capacity Act 2005, and where the Mental Health Act 1983 applies, follow that Act. See CQC Regulation 11.
- Regular Reviews: Regularly review the patient’s condition and the ongoing need for chemical restraint.
- Training and Education: Staff should be well-trained in both the use of chemical restraints and alternative strategies.
Final Thoughts
Chemical restraint should be a last resort that is rare, lawful, necessary and proportionate, and it carries serious risks. Its application requires balancing the need for safety with respect for autonomy and ethical considerations. Always explore alternatives and ensure practices comply with legal standards. Mechanical restraints in healthcare systems should only be used as a last resort and for the shortest time possible. Regular monitoring and assessment of the individual’s condition is crucial to ensure the necessity of restraint. It is also important to involve the individual and their family or caregivers in the decision-making process, while taking into account their preferences and beliefs. Ultimately, the goal should be to promote the individual’s well-being and dignity while maintaining a safe and secure environment.
By understanding the complexities and striving for compassionate care, we can minimise the need for chemical restraint, ensuring any restraint is necessary and a proportionate response to a risk of harm, as CQC Regulation 13 requires.